4//SEC Filing
Ginski Mark J 4
Accession 0001415889-21-000508
CIK 0001411685other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:17 PM ET
Size
5.5 KB
Accession
0001415889-21-000508
Insider Transaction Report
Form 4
Ginski Mark J
SENIOR VP, HEAD OF CMC
Transactions
- Award
Stock Options (Right to Buy)
2021-02-01+200,000→ 200,000 totalExercise: $2.14Exp: 2031-02-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares vest on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter over a period of three (3) years, becoming fully vested on February 1, 2025.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001843460
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:17 PM ET
- Size
- 5.5 KB